Cite
MLA Citation
Paul E Sax et al.. “Bictegravir versus dolutegravir, each with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection: a randomised, double-blind, phase 2 trial.” Lancet, vol. 4, no. 4, 2017, pp. e154–e160. http://access.bl.uk/ark:/81055/vdc_100045163145.0x000017